Want to join the conversation?
In 3Q15, $REGN's non-GAAP SG&A expenses were $174MM, a sequential increase of 22% vs. 2Q15 and a 111% versus 3Q14. These percent increases are in line with expectations and are primarily driven the commercialization expenses to launch Praluent.
$EXTR has been on an interesting uptrend, fundamentals kinda tricky but solid technical. Earnings 5th